PlainRecalls
FDA Drug Moderate Class II Terminated

Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.

Reported: April 26, 2023 Initiated: March 16, 2023 #D-0536-2023

Product Description

Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.

Reason for Recall

Failed Dissolution Specifications: Out of specification dissolution results above specified values.

Details

Units Affected
695 cartons
Distribution
Nationwide in the USA
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.. Recalled by Amerisource Health Services LLC. Units affected: 695 cartons.
Why was this product recalled?
Failed Dissolution Specifications: Out of specification dissolution results above specified values.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 26, 2023. Severity: Moderate. Recall number: D-0536-2023.